ozempic semaglutide or tirzepatide EASO Recommends Semaglutide, for First-Line Obesity Therapy Semaglutide & tirzepatide are transforming

No large, prospective trial has formally documented a specific failure rate, because major GLP-1 trials did not target contraceptive users

R.BatraG.SainiL.SharmaS.MishraA.SinglaR.et al

This approach allows for continued GLP-1 therapy, avoiding disruptions in glycemic control and cardiovascular protection [1, 2], while still maintaining patient safety

Synthetic FXR agonist GW4064 prevents Diet-Induced hepatic steatosis and insulin resistance

In addition, mitochondria also produce a large amount of ROS during normal metabolism and the generation of cellular energy via the electron transport chain, leading to cell and tissue damage [36]

Stop Use & Seek Medical Advice If: You experience any adverse reactions